Trillium Therapeutics tau txais qhov kev pom zoo los ntawm Hold. Lub tuam txhab qhov qhab nia nruab nrab yog 2.33, thiab yog raws li 2 yuav kev ntaus nqi, 4 tuav kev ntaus nqi, thiab tsis muaj kev muag khoom.
Yuav Trillium Therapeutics nce mus?
Yuav Trillium Therapeutics Tshuag nqi nce / nce / nce? Yes. Tus nqi TRIL tuaj yeem nce los ntawm 17.755 USD rau 23.799 USD hauv ib xyoos.
Puas TRIL Tshuag yog qhov yuav zoo?
Tawm ntawm 5 tus kws tshuaj ntsuam xyuas, 1 (20%) tau pom zoo TRIL raws li Kev Yuav Muaj Zog, 1 (20%) tau pom zoo TRIL li Kev Yuav, 3 (60%) tau pom zoo TRIL li Hold, 0 (0%) tau pom zoo TRIL li Muag, thiab 0 (0%) tau pom zoo TRIL li Kev Muag Khoom Zoo.
Puas Acorda Therapeutics yog kev nqis peev zoo?
Kev ntsuas ntsuas ntsuas qhia tau tias Acorda Therapeutics, Inc. yuav raug nqi ntau dua. Nws Tus Nqi Qis D qhia tias nws yuav yog tus xaiv tsis zoo rau tus nqi nqis peev. Kev noj qab haus huv nyiaj txiag thiab kev loj hlob ntawm ACOR, qhia txog nws lub peev xwm los ua lag luam tsis zoo.
Pfizer puas yuav Trillium Therapeutics?
Pfizer tau kos npe rau daim ntawv cog lus meej kom tau txais txhua yamcov khoom lag luam zoo tshaj plaws ntawm cov chaw kho mob-theem immuno-oncology tuam txhab Trillium Therapeutics rau cov nqi sib npaug ntawm $ 2.26bn, lossis $ 18.50 ib feem., hauv nyiaj ntsuab. … Qhov sib ntxiv ntawm cov tshuaj tiv thaiv kab mob no yuav tsum txhawb nqa Pfizer qhov muaj nyob hauv thaj chaw oncology.
